SurModics Inc., a provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced in November that they signed a license agreement for NP201, the first long-acting treatment available in broadly acceptable dose form that maintains the potential to provide sustained relief from Parkinson’s disease without motor response complications.
Hamilton Robotics has introduced the MICROLAB NIMBUS Heater/Shaker Package, an integrated system that incorporates high-speed automated pipetting with orbital plate shaking and heating.
Bio-Rad Laboratories Inc. has launched the iScript RT-qPCR Sample Preparation Reagent for rapid isolation of total RNA and enabling reverse transcription and real-time PCR to be performed directly from cell lysates.
Collaborations between data and computation-driven systems biology companies and forward-thinking oncology clinics are poised to change the face of cancer drug development and cancer itself.
Is Bilski important? Some estimates say as many as 200,000 patents could be invalidated if Bilski is held to strictly apply to all method patents. For the biotech industry, the decision has significant ramifications for the patentability of many inventions, particularly diagnostics and personalized medicine.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.